Chronic fluoxetine treatment has a larger effect on the density of a serotonin transporter in the Flinders Sensitive Line (FSL) rat model of depression than in normal rats

Synapse

Volumn 64, Issue 3, 2010, Pages 231-240

  Kovačević, Tomislav ^a,b   Skelin, Ivan ^a,c   Diksic, Mirko ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^c UNIVERSITY OF SPLIT   (Croatia)

Author keywords

125I RTI 55; Animal; Autoradiography; Depression; Disease models; Fluoxetine; Rat; SERT protein

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; 3BETA (4 IODOPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; FLUOXETINE; IODINE 125; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FLINDERS SENSITIVE LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RAT STRAIN; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; AUTORADIOGRAPHY; BRAIN; DEPRESSION; DISEASE MODELS, ANIMAL; FLUOXETINE; NEURONS; PROTEIN BINDING; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SPECIES SPECIFICITY;

EID: 73449131886     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20721     Document Type: Article

References (62)

1. Ballard C, Johnson M, Piggott M, Perry R, O'Brien J, Rowan E, Perry E, Lantos P, Cairns N, Holmes C. 2002. A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies. J Affect Disord 69:219-223.
2. Bel N, Artigas F. 1993. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15:243-245.
3. Benmansour S, Cecchi M, Morilak DA, Gerhardt GA, Javors MA, Gould GG, Frazer A. 1999. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci 19:10494-10501.
4. Benson DF. 1984. The neurology of human emotion [Review]. Bull Clin Neurosci 49:23-42.
5. Bertrand PP, Hu X, Mach J, Bertrand RL. 2008. Serotonin (5-HT) release and uptake measured by real-time electrochemical techniques in the rat ileum. Am J Physiol Gastrointest Liver Physiol 295:G1228-G1236.
6. Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, DeFelice LJ. 1998. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins [Review]. Biol Psychiatry 44:169-178.
7. 125I]RTI-55 to dopamine and serotonin transporters in rat brain. Synapse 12: 27-36.
8. Bosker FJ, Klompmakers AA, Westenberg HG. 1995. Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology 34:501-508.
9. Caccia S, Confalonieri S, Bergami A, Fracasso C, Anelli M, Garattini S. 1997. Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: A comparison with fluoxetine. Pharmacol Biochem Behav 57:851-856.
10. Charles M, Beasley , Daniel N, Masica, Janet H, Potvin 1992. Fluoxetine: A review of receptor and functional effect and their clinical implications Psychopharmacology 107:1-10
11. Daniels GM, Amara SG. 1999. Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters. J Biol Chem 274: 35794-35801.
12. Daws LC, Overstreet DH. 1999. Ontogeny of muscarinic cholinergic supersensitivity in the Flinders Sensitive Line rat. Pharmacol Biochem Behav 62:367-380.
13. De Souza EB, Kuyatt BL. 1987. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain. Synapse 1:488-496.
14. Dryden S, Frankish HM, Wang Q, Pickavance L, Williams G. 1996. The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats. Neuroscience 72:557-566.
15. D'Souza DN, Zhang Y, Garcia F, Battaglia G, Van De Kar LD. 2002. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors. Psychopharmacology (Berl) 164:392-400.
16. Elfving B, Madsen J, Knudsen GM. 2007. Neuroimaging of the serotonin reuptake site requires high-affinity ligands. Synapse 61: 882-888.
17. Gillin JC, Kelsoe JR Jr, Kaufman CA, Kleinman JE, Risch SC, Janowsky DS. 1986. Muscarinic receptor density in skin fibroblasts and autopsied brain tissue in affective disorder. Ann NY Acad Sci 487:143-149.
18. Gobbi M, Crespi D, Foddi MC, Fracasso C, Mancini L, Parotti L, Mennini T. 1997. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT1B autoreceptors, 5-HT3 and 5-HT4 receptors in rats. Naunyn Schmiedebergs Arch Pharmacol 356:22-28.
19. Guilloteau D, Chalon S. 2005. PET and SPECT exploration of central monoaminergic transporters for the development of new drugs and treatments in brain disorders. Curr Pharm Des 11: 3237-3245.
20. Hasegawa S, Nishi K, Watanabe A, Overstreet DH, Diksic M. 2006. Brain 5-HT synthesis in the Flinders Sensitive Line rat model of depression: An autoradiographic study. Neurochem Int 48: 358-366.
21. Hébert C, Habimana A, Elie R, Reader TA. 2001. Effects of chronic antidepressant treatments on 5-HT and NA transporters in rat brain: An autoradiographic study. Neurochem Int 38:63-74.
22. Horschitz S, Hummerich R, Schloss P. 2001. Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor Neuroreport 12:2181-2184.
23. Hranilovic D, Cicin-Sain L, Bordukalo-Niksic T, Jernej B. 2005. Rats with constitutionally upregulated/downregulated platelet 5HT transporter: Differences in anxiety-related behavior. Behav Brain Res 165:271-277.
24. Hrdina PD. 1987. Regulation of high- and low-affinity [3H]imipramine recognition sites in rat brain by chronic treatment with antidepressants. Eur J Pharmacol 138:159-168.
25. Hrdina PD, Vu TB. 1993. Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: An autoradiographic study. Synapse 14:324-331.
26. Hwang EC, Magnussen I, Van Woert MH. 1980. Effects of chronic fluoxetine administration on serotonin metabolism. Res Commun Chem Pathol Pharmacol 29:79-98.
27. Janowsky DS, Overstreet DH, Nurnberger JI Jr 1994. Is cholinergic sensitivity a genetic marker for the affective disorders? Am J Med Genet 54:335-344.
28. Kanemaru K, Hasegawa S, Nishi K, Diksic M. 2008. Acute citalopram has different effects on regional 5-HT synthesis in FSL, FRL, and SDP rats: An autoradiographic evaluation. Brain Res Bull 77:214-220.
29. Kanemaru K, Nishi K, Hasegawa S, Diksic M. 2009. Chronic citalopram treatment elevates serotonin synthesis in flinders sensitive and flinders resistant lines of rats, with no significant effect on Sprague-Dawley rats. Neurochem Int 54:363-371.
30. Kimura R, Miwa M, Kato Y, Sato M, Yamada S. 1991. Relationship between nasal absorption and physicochemical properties of quaternary ammonium compounds. Arch Int Pharmacodyn Ther 310: 13-21.
31. Larsen Mads Breum, Betina Elfving, Ove Wiborg. 2004. The chicken serotonin transporter discriminates between serotonin-selective reuptake inhibitors. J Biol Chem 279:42147-42156.
32. 123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44:1090-1098.
33. Mattsson H, Arani Z, Astin M, Bayati A, Overstreet DH, Lehmann A. 2005. Altered neuroendocrine response and gastric dysmotility in the Flinders Sensitive Line rat. Neurogastroenterol Motil 17: 166-174.
34. Meltzer HY, Maes M. 1995. Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biol Psychiatry 38: 450-457.
35. Meyer JH, Wilson AA, Ginovart N, Goulding V, Hussey D, Hood K, Houle S. 2001. Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: A [(11)C]DASB PET imaging study. Am J Psychiatry 158:1843-1849.
36. Mück-Šeler D, Jevric-Causevic A, Diksic M. 1996. Influence of fluoxetine on regional serotonin synthesis in the rat brain. J Neurochem 67:2434-2442.
37. 3H] paroxetine binding to serotonin transporters in rat brain. Neurochem Res 33:2250-2256.
38. Neumaier JF, Root DC, Hamblin MW. 1996. Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus. Neuropsychopharmacology 15:515-522.
39. Nishi K, Kanemaru K, Diksic M. 2009a. A genetic rat model of depression, Flinders sensitive line has a lower density of 5-HT1A receptors, but a higher density of 5-HT1B receptors, compared to control rats; Neurochem Int 54:299-307.
40. Nishi K, Kanemaru K, Hasegawa S, Watanabe A, Diksic M. 2009b. Both acute and chronic buspirone treatments have different effects on regional 5-HT synthesis in Flinders Sensitive Line rats (a rat model of depression) than in control rats. Neurochem Int 54:205-214.
41. Okazawa H, Yamane F, Blier P, Diksic M. 1999. Effects of acute and chronic administration of the serotonin1A agonist buspirone on serotonin synthesis in the rat brain. J Neurochem 72: 2022-2031.
42. Overstreet DH. 2002. Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists [Review]. Behav Genet 32: 335-348.
43. Overstreet DH, Friedman E, Mathe' AA, Yadid G. 2005. The flinders sensitive line rat: A selectively bred putative animal model of depression. Neurosci Biobehav Rev 29:739-759.
44. Overstreet DH, Hlavka J, Feighner JP, Nicolau G, Freed JS. 2004. Antidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depression. Psychopharmacology (Berl) 175: 303-309.
45. Overstreet DH, Russell RW, Helps SC, Messenger M. 1979. Selective breeding for sensitivity to the anticholinesterase DFP. Psychopharmacology (Berl) 65:15-20.
46. Paxinos G, Watson C. 1997. The rat brain atlas in stereotaxic coordinates, compact,3rd ed. New York: Academic Press.
47. Perry EK, Marchall EF, Blessed G, Tomlinson BE, Perry R H,. 1983. Decreased imipramine binding in the brains of patients with depressive illness. Brit J Psychiatry 142:188-192.
48. Pirker W, Asenbaum S, Kasper S, Walter H, Angelberger P, Koch G, Pozzera A, Deecke L, Podreka I, Brücke T. 1995. beta-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. J Neural Transm Gen 100: 247-256.
49. Ramamoorthy S, Blakely DR. 1999. Phosphorilation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285:763-766.
50. 3H]paroxetine binding sites in platelets from depressed patients. J Affect Disord 52:225-233.
51. Rothman RB, Cadet JL, Akunne HC, Silverthorn ML, Baumann MH, Carroll FI, Rice KC, De Costa BR, Partilla JS, Wang J-B, Uhl G, Glowa JR, Dersch CM. 1994. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55. J Pharmacol Exp Ther 270:296-309.
52. Saito H, Matsumoto M, Togashi H, Yoshioka M. 1996. Functional interaction between serotonin and other neuronal systems: Focus on in vivo microdialysis studies [Review]. Jpn J Pharmacol 70: 203-205.
53. Shayit M, Yadid G, Overstreet DH, Weller A. 2003. 5-HT(1A) receptor subsensitivity in infancy and supersensitivity in adulthood in an animal model of depression. Brain Res 980:100-108.
54. 18F]MPPF binding potential in the dorsal raphe nucleus after a single oral dose of fluoxetine: A positron-emission tomography study in healthy volunteers. Biol Psychiatry 63:1135-1140.
55. Stanley M, Virgilio J, Gershon S. 1982. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 216:1337-1339.
56. Stockmeier CA. 1997. Neurobiology of serotonin in depression and suicide. Ann NY Acad Sci 836:220-232.
57. van Harten J. 1993. Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clin Pharmacokinet 24:203-220.
58. 11C]DASB positron emission tomography. Psychopharmacology (Berl) 193:539-545.
59. Wong DT, Reid LR, Bymaster FP, Threlkeld PG. 1985. Chronic effects of fluoxetine, a selective inhibitor of serotonin uptake, on neurotransmitter receptors. J Neural Transm 64:251-269.
60. Yadid G, Nakash R, Deri I, Tamar G, Kinor N, Gispan I, Zangen A. 2000. Elucidation of the neurobiology of depression: Insights from a novel genetic animal model. Prog Neurobiol 62:353-378.
61. Zangen A, Overstreet DH, Yadid G. 1997. High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: Normalization by chronic antidepressant treatment. J Neurochem 69:2477-2483.
62. Zangen AR, Nakash R, Overstreet DH, Yadid G. 2001. Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens. Psychopharmacology 155:434-439.